B. Amzal

发表

Investigating combined toxicity of binary mixtures in bees: Meta-analysis of laboratory tests, modelling, mechanistic basis and implications for risk assessment.

E. Benfenati, J. Dorne, A. Rortais, 2019, Environment international.

Use of historical control data for assessing treatment effects in clinical trials

Fang Chen, Satrajit Roychoudhury, Beat Neuenschwander, 2014, Pharmaceutical statistics.

A retrospective observational analysis of post-pandemic influenza-related outcomes in the United Kingdom, 2010–2014

B. Blak, B. Amzal, J. Hackett, 2017, Human vaccines & immunotherapeutics.

Bayesian-Optimal Design via Interacting Particle Systems

Christian P. Robert, Frédéric Y. Bois, Eric Parent, 2006 .

Sequential Updating of a New Dynamic Pharmacokinetic Model for Caffeine in Premature Neonates

Frédéric Y. Bois, Pierre Tourneux, Billy Amzal, 2007, Clinical pharmacokinetics.

The Yin–Yang of CYP3A4: a Bayesian meta-analysis to quantify inhibition and induction of CYP3A4 metabolism in humans and refine uncertainty factors for mixture risk assessment

J. Dorne, N. Quignot, B. Amzal, 2018, Archives of Toxicology.

A Randomised Clinical Trial in Men with Low-risk Prostate Cancer

C. Stief, G. Salomon, F. Kleinclauss, 2017 .

Development and validation of a Bayesian survival model for inclusion body myositis

T. Obadia, G. Capkun, V. Risson, 2019, Theoretical Biology and Medical Modelling.

Data collection on toxicokinetic and toxicodynamic interactions of chemical mixtures for human risk assessment

N. Quignot, B. Amzal, C. Béchaux, 2015 .

Relation between dietary cadmium intake and biomarkers of cadmium exposure in premenopausal women accounting for body iron stores

A. Wolk, M. Berglund, M. Vahter, 2011, Environmental health : a global access science source.

Inter-phenotypic differences in CYP2C9 and CYP2C19 metabolism: Bayesian meta-regression of human population variability in kinetics and application in chemical risk assessment.

J. Dorne, N. Quignot, B. Amzal, 2020, Toxicology letters.

TECHNICAL REPORT OF EFSA Meta-analysis of Dose-Effect Relationship of Cadmium for Benchmark

J. Dorne, E. Christoph, B. Amzal, 2009 .

Population Toxicokinetic Modeling of Cadmium for Health Risk Assessment

A. Wolk, M. Vahter, A. Åkesson, 2009, Environmental health perspectives.

Arti ﬁ cial Intelligence and Machine Learning Applied at the Point of Care

Billy Amzal, Anthe S. Zandvliet, Thomas Kerbusch, 2022 .

A sample size calculation of Bayesian design for superiority trials with rare events

Lily Ingsrisawang, Billy Amzal, Tim R. Cressey, 2016 .

Perinatal antiretroviral intensification to prevent intrapartum HIV transmission when antenatal antiretroviral therapy is initiated less than 8 weeks prior to delivery.

S. Urien, V. Klinbuayaem, B. Amzal, 2020, Journal of acquired immune deficiency syndromes.

Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV

S. Urien, K. Mcintosh, B. Amzal, 2015, PloS one.

A generic Bayesian hierarchical model for the meta-analysis of human population variability in kinetics and its applications in chemical risk assessment

W Wiecek, Jean-Lou Dorne, Nadia Quignot, 2019, Computational Toxicology.

Resistance Patterns Selected by Nevirapine vs. Efavirenz in HIV-Infected Patients Failing First-Line Antiretroviral Treatment: A Bayesian Analysis

K. Mcintosh, B. Amzal, M. Lallemant, 2011, PloS one.

Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial.

Antonio Alcaraz, Jens Rassweiler, Christian Gratzke, 2017, The Lancet. Oncology.

Clinical and economic burden of severe asthma: A French cohort study.

M. Humbert, T. Similowski, N. Roche, 2018, Respiratory medicine.

Population effects and variability.

Jean Lou Dorne, Amélie Crépet, Billy Amzal, 2012, Methods in molecular biology.

Challenges for Optimizing Real-World Evidence in Alzheimer’s Disease: The ROADMAP Project

John Gallacher, Andrew Turner, Jacoline C. Bouvy, 2018, Journal of Alzheimer's disease : JAD.

Second-line cabozantinib versus nivolumab in advanced renal cell carcinoma: Systematic review and indirect treatment comparison.

C. Porta, J. Dinet, C. Szczylik, 2019, Critical reviews in oncology/hematology.

Human risk assessment of heavy metals: principles and applications.

J. Dorne, A. Boobis, E. Dogliotti, 2010, Metal ions in life sciences.

A statistical assessment of differences and equivalences between genetically modified and reference plant varieties

J. Perry, H. van der Voet, B. Amzal, 2011, BMC biotechnology.

Data collection on Combined Toxicity of Multiple Chemicals for Animal Health and Ecological Risk Assessment

N. Quignot, B. Amzal, Audrey Grech, 2015 .

Correction: Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV

S. Urien, K. Mcintosh, B. Amzal, 2015, PloS one.

Cabozantinib versus everolimus, nivolumab, axitinib, sorafenib and best supportive care: A network meta-analysis of progression-free survival and overall survival in second line treatment of advanced renal cell carcinoma

B. Amzal, J. Lister, H. Karcher, 2017, PloS one.

Human variability in polymorphic CYP2D6 metabolism: Implications for the risk assessment of chemicals in food and emerging designer drugs.

J. Dorne, E. Testai, B. Amzal, 2021, Environment international.

An Indirect Comparison of Everolimus Versus Axitinib in US Patients With Advanced Renal Cell Carcinoma in Whom Prior Sunitinib Therapy Failed.

Billy Amzal, Zhimei Liu, E. Calvo, 2015, Clinical therapeutics.

Joint Calibration of Option Pricing Models Via Particle Methods

B. Amzal, S. Roland, Yonathan Ebguy, 2005 .

Applicability and Feasibility of Systematic Review for Performing Evidence-Based Risk Assessment in Food and Feed Safety

J Glanville, J P T Higgins, G L Lövei, 2015, Critical reviews in food science and nutrition.

Rivastigmine exposure provided by a transdermal patch versus capsules

H. Schmidli, G. Lefèvre, B. Amzal, 2007, Current medical research and opinion.

Combining analytical techniques, exposure assessment and biological effects for risk assessment of chemicals in food

Philippe Verger, Billy Amzal, Pietro Ferrari, 2009 .

PND81 PREDICTION OF ALZHEIMER'S DISEASE (AD) FROM ASYMPTOMATIC STAGES USING MACHINE LEARNING (ML) MODELS

B. Amzal, S. Huang, L. Qi-Gautier, 2020 .

Pragmatic Multicriteria Decision Analysis (MCDA) Combined With Advanced Pharmacoepidemiology for Benefit-Risk Assessments of Medicines Adapted to the Real-Life Constraints of Regulators: Development and Case Study

Mateusz Nikodem, Mireille M Goetghebeur, Alain Micaleff, 2016, Therapeutic innovation & regulatory science.

Impact of increased influenza vaccination in 2–3-year-old children on disease burden within the general population: A Bayesian model-based approach

Billy Amzal, B. Blak, B. Amzal, 2017, PloS one.

A weighted-adjusted indirect comparison of everolimus (EVE) versus axitinib (AXI) in second-line metastatic renal cell carcinoma (mRCC) patients who previously failed sunitinib therapy.

E. Calvo, B. Amzal, Xufang Wang, 2014 .

Antiretroviral intensification to prevent intrapartum HIV transmission in late comers

S. Urien, B. Amzal, T. Cressey, 2015 .

Use of historical control data for assessing treatment effects in clinical trials

J. Ibrahim, S. Lindborg, B. Hobbs, 2014, Pharmaceutical statistics.

Artificial Intelligence and Machine Learning Applied at the Point of Care

Niedre M. Heckman, A. Zandvliet, H. Sotoudeh, 2020, Frontiers in Pharmacology.